These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

641 related articles for article (PubMed ID: 33271067)

  • 1. Cryo-EM Structures of SARS-CoV-2 Spike without and with ACE2 Reveal a pH-Dependent Switch to Mediate Endosomal Positioning of Receptor-Binding Domains.
    Zhou T; Tsybovsky Y; Gorman J; Rapp M; Cerutti G; Chuang GY; Katsamba PS; Sampson JM; Schön A; Bimela J; Boyington JC; Nazzari A; Olia AS; Shi W; Sastry M; Stephens T; Stuckey J; Teng IT; Wang P; Wang S; Zhang B; Friesner RA; Ho DD; Mascola JR; Shapiro L; Kwong PD
    Cell Host Microbe; 2020 Dec; 28(6):867-879.e5. PubMed ID: 33271067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cryo-EM Structures Delineate a pH-Dependent Switch that Mediates Endosomal Positioning of SARS-CoV-2 Spike Receptor-Binding Domains.
    Zhou T; Tsybovsky Y; Olia AS; Gorman J; Rapp MA; Cerutti G; Chuang GY; Katsamba PS; Nazzari A; Sampson JM; Schon A; Wang PD; Bimela J; Shi W; Teng IT; Zhang B; Boyington JC; Sastry M; Stephens T; Stuckey J; Wang S; Friesner RA; Ho DD; Mascola JR; Shapiro L; Kwong PD
    bioRxiv; 2020 Jul; ():. PubMed ID: 32637958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural basis and analysis of hamster ACE2 binding to different SARS-CoV-2 spike RBDs.
    Niu S; Zhao Z; Liu Z; Rong X; Chai Y; Bai B; Han P; Shang G; Ren J; Wang Y; Zhao X; Liu K; Tian W-x; Wang Q; Gao GF
    J Virol; 2024 Mar; 98(3):e0115723. PubMed ID: 38305152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2.
    Huo J; Le Bas A; Ruza RR; Duyvesteyn HME; Mikolajek H; Malinauskas T; Tan TK; Rijal P; Dumoux M; Ward PN; Ren J; Zhou D; Harrison PJ; Weckener M; Clare DK; Vogirala VK; Radecke J; Moynié L; Zhao Y; Gilbert-Jaramillo J; Knight ML; Tree JA; Buttigieg KR; Coombes N; Elmore MJ; Carroll MW; Carrique L; Shah PNM; James W; Townsend AR; Stuart DI; Owens RJ; Naismith JH
    Nat Struct Mol Biol; 2020 Sep; 27(9):846-854. PubMed ID: 32661423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies.
    Barnes CO; Jette CA; Abernathy ME; Dam KA; Esswein SR; Gristick HB; Malyutin AG; Sharaf NG; Huey-Tubman KE; Lee YE; Robbiani DF; Nussenzweig MC; West AP; Bjorkman PJ
    Nature; 2020 Dec; 588(7839):682-687. PubMed ID: 33045718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The structural basis of accelerated host cell entry by SARS-CoV-2†.
    Seyran M; Takayama K; Uversky VN; Lundstrom K; Palù G; Sherchan SP; Attrish D; Rezaei N; Aljabali AAA; Ghosh S; Pizzol D; Chauhan G; Adadi P; Mohamed Abd El-Aziz T; Soares AG; Kandimalla R; Tambuwala M; Hassan SS; Azad GK; Pal Choudhury P; Baetas-da-Cruz W; Serrano-Aroca Á; Brufsky AM; Uhal BD
    FEBS J; 2021 Sep; 288(17):5010-5020. PubMed ID: 33264497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of SARS-CoV-2 B.1.1.7 mutations on spike protein structure and function.
    Yang TJ; Yu PY; Chang YC; Liang KH; Tso HC; Ho MR; Chen WY; Lin HT; Wu HC; Hsu SD
    Nat Struct Mol Biol; 2021 Sep; 28(9):731-739. PubMed ID: 34385690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis for receptor-binding domain mobility of the spike in SARS-CoV-2 BA.2.86 and JN.1.
    Yajima H; Anraku Y; Kaku Y; Kimura KT; Plianchaisuk A; Okumura K; Nakada-Nakura Y; Atarashi Y; Hemmi T; Kuroda D; Takahashi Y; Kita S; Sasaki J; Sumita H; ; Ito J; Maenaka K; Sato K; Hashiguchi T
    Nat Commun; 2024 Oct; 15(1):8574. PubMed ID: 39375326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. V367F Mutation in SARS-CoV-2 Spike RBD Emerging during the Early Transmission Phase Enhances Viral Infectivity through Increased Human ACE2 Receptor Binding Affinity.
    Ou J; Zhou Z; Dai R; Zhang J; Zhao S; Wu X; Lan W; Ren Y; Cui L; Lan Q; Lu L; Seto D; Chodosh J; Wu J; Zhang G; Zhang Q
    J Virol; 2021 Jul; 95(16):e0061721. PubMed ID: 34105996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bat and pangolin coronavirus spike glycoprotein structures provide insights into SARS-CoV-2 evolution.
    Zhang S; Qiao S; Yu J; Zeng J; Shan S; Tian L; Lan J; Zhang L; Wang X
    Nat Commun; 2021 Mar; 12(1):1607. PubMed ID: 33707453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2.
    Yan R; Zhang Y; Li Y; Xia L; Guo Y; Zhou Q
    Science; 2020 Mar; 367(6485):1444-1448. PubMed ID: 32132184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Genetic Variability in ACE2 Expression on the Evolutionary Dynamics of SARS-CoV-2 Spike D614G Mutation.
    Huang SW; Miller SO; Yen CH; Wang SF
    Genes (Basel); 2020 Dec; 12(1):. PubMed ID: 33374416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural characteristics of BtKY72 RBD bound to bat ACE2 reveal multiple key residues affecting ACE2 usage of sarbecoviruses.
    Su C; He J; Wang L; Hu Y; Cao J; Bai B; Qi J; Gao GF; Yang M; Wang Q
    mBio; 2024 Sep; 15(9):e0140424. PubMed ID: 39082798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cryo-EM structure of a SARS-CoV-2 omicron spike protein ectodomain.
    Ye G; Liu B; Li F
    Nat Commun; 2022 Mar; 13(1):1214. PubMed ID: 35241675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural Basis of a Human Neutralizing Antibody Specific to the SARS-CoV-2 Spike Protein Receptor-Binding Domain.
    Yang M; Li J; Huang Z; Li H; Wang Y; Wang X; Kang S; Huang X; Wu C; Liu T; Jia Z; Liang J; Yuan X; He S; Chen X; Zhou Z; Chen Q; Liu S; Li J; Zheng H; Liu X; Li K; Yao X; Lang B; Liu L; Liao HX; Chen S
    Microbiol Spectr; 2021 Oct; 9(2):e0135221. PubMed ID: 34643438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Competitive SARS-CoV-2 Serology Reveals Most Antibodies Targeting the Spike Receptor-Binding Domain Compete for ACE2 Binding.
    Byrnes JR; Zhou XX; Lui I; Elledge SK; Glasgow JE; Lim SA; Loudermilk RP; Chiu CY; Wang TT; Wilson MR; Leung KK; Wells JA
    mSphere; 2020 Sep; 5(5):. PubMed ID: 32938700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced Binding of SARS-CoV-2 Spike Protein to Receptor by Distal Polybasic Cleavage Sites.
    Qiao B; Olvera de la Cruz M
    ACS Nano; 2020 Aug; 14(8):10616-10623. PubMed ID: 32806067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in the SARS-CoV-2 spike receptor binding domain and their delicate balance between ACE2 affinity and antibody evasion.
    Xue S; Han Y; Wu F; Wang Q
    Protein Cell; 2024 May; 15(6):403-418. PubMed ID: 38442025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Basis of Mink ACE2 Binding to SARS-CoV-2 and Its Mink-Derived Variants.
    Su C; He J; Han P; Bai B; Li D; Cao J; Tian M; Hu Y; Zheng A; Niu S; Chen Q; Rong X; Zhang Y; Li W; Qi J; Zhao X; Yang M; Wang Q; Gao GF
    J Virol; 2022 Sep; 96(17):e0081422. PubMed ID: 36000849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of common mutations in the SARS-CoV-2 Spike RBD and its ligand, the human ACE2 receptor on binding affinity and kinetics.
    Barton MI; MacGowan SA; Kutuzov MA; Dushek O; Barton GJ; van der Merwe PA
    Elife; 2021 Aug; 10():. PubMed ID: 34435953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.